ICU Medical holder plans sale of 5,417 shares

ICU Medical shareholder Daniel Woolson filed to sell 5,417 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $982,264.61, expected on 08/13/2026 on NASDAQ.

Rhea-AI Filing Summary

ICU Medical shareholder Daniel Woolson filed to sell 5,417 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $982,264.61, expected on 08/13/2026 on NASDAQ. In the past three months, Woolson reported selling 2,123 shares on 05/22/2026 for $280,684.80. The filing also lists multiple sources of these shares, including performance stock units and restricted stock vesting under a registered plan with various grant or vesting dates and share amounts.

Key Figures

Shares planned for sale: 5,417 shares Aggregate market value of planned sale: $982,264.61 Planned sale date: 08/13/2026 +5 more

8 metrics

Shares planned for sale 5,417 shares Common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services

Aggregate market value of planned sale $982,264.61 Total market value of 5,417 ICU Medical common shares

Planned sale date 08/13/2026 Expected NASDAQ transaction date for 5,417 shares

Recent shares sold 2,123 shares Common stock sold on 05/22/2026 during the past 3 months

Proceeds from recent sale $280,684.80 Total proceeds from 2,123 shares sold on 05/22/2026

Performance Stock Units 02/14/2020 449 units Performance Stock Units dated 02/14/2020 listed as a source of common shares

Performance Stock Units 03/07/2024 1,100 units Performance Stock Units dated 03/07/2024 listed as a source of common shares

Restricted stock vesting 03/08/2025 1,200 shares Restricted Stock Vesting Under a Registered Plan dated 03/08/2025

Key Terms

Performance Stock Units, Restricted Stock Vesting Under a Registered Plan, Executive Financial Services

3 terms

Performance Stock Units financial

"Common | 02/14/2020 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Restricted Stock Vesting Under a Registered Plan financial

"Common | 03/07/2024 | Restricted Stock Vesting Under a Registered Plan"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed in ICU Medical (ICUI)'s recent filing?

The filing discloses a planned sale of 5,417 shares of ICU Medical common stock with an aggregate market value of $982,264.61, expected to be executed on 08/13/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

Who is selling ICU Medical (ICUI) shares and through which broker?

Shareholder Daniel Woolson plans to sell ICU Medical common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, according to the disclosed transaction details.

How many ICU Medical (ICUI) shares were sold recently and for how much?

Within the past three months, 2,123 shares of ICU Medical common stock were sold on 05/22/2026 for total proceeds of $280,684.80, as reported in the sales history section associated with this seller.

What is the market value of the ICU Medical (ICUI) shares planned for sale?

The planned sale covers 5,417 shares of ICU Medical common stock with an aggregate market value of $982,264.61, based on the pricing information provided for the anticipated NASDAQ transaction on 08/13/2026.

What types of awards are linked to the ICU Medical (ICUI) shares being sold?

The shares relate to Performance Stock Units and Restricted Stock Vesting Under a Registered Plan with dates including 02/14/2020, 03/07/2024, 03/07/2025, 03/08/2025, and 03/15/2025, totaling several grant and vesting lots.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:18 PM Accepted by SEC EDGAR 08/13/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001698998
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ICU MEDICAL, INC.
SEC File Number	001-34634
Address of Issuer	951 Calle Amanecer San Clemente CALIFORNIA 92673
Phone	(949) 366-2183
Name of Person for Whose Account the Securities are To Be Sold	DANIEL WOOLSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5417	982264.61	25007038	08/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2020	Performance Stock Units	Issuer			449	02/14/2020	Not Applicable
Common	03/07/2024	Performance Stock Units	Issuer			1100	03/07/2024	Not Applicable
Common	03/07/2024	Restricted Stock Vesting Under a Registered Plan	Issuer			540	03/07/2024	Not Applicable
Common	03/07/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			499	03/07/2025	Not Applicable
Common	03/08/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			1200	03/08/2025	Not Applicable
Common	03/15/2025	Performance Stock Units	Issuer			1629	03/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL WOOLSON 951 Calle Amanecer San Clemente CA 92673	Common	05/22/2026	2123	280684.80

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Christopher Woolson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)